Terms: = Liver cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Diagnosis
45 results:
1. Minimally invasive liver resection for cholangiolocellular carcinoma: A single-institution experience.
Kihara Y; Takeda Y; Ohmura Y; Katsura Y; Shinke G; Kinoshita M; Aoyama S; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
Asian J Endosc Surg; 2024 Jan; 17(1):e13272. PubMed ID: 38212270
[TBL] [Abstract] [Full Text] [Related]
2. Focal fatty sparing areas of the pediatric steatotic liver: pseudolesions on hepatobiliary phase magnetic resonance images.
Özer G; Özcan HN; Oğuz B; Haliloğlu M
Diagn Interv Radiol; 2024 Mar; 30(2):135-138. PubMed ID: 38032244
[TBL] [Abstract] [Full Text] [Related]
3. Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019.
Nasr P; von Seth E; Mayerhofer R; Ndegwa N; Ludvigsson JF; Hagström H
Eur J Epidemiol; 2023 Sep; 38(9):973-984. PubMed ID: 37490175
[TBL] [Abstract] [Full Text] [Related]
4. Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
Johira Y; Nakahara T; Kinami T; Yamasaki S; Kosaka M; Shirane Y; Miura R; Murakami S; Yano S; Amioka K; Naruto K; Ando Y; Kosaka Y; Kodama K; Uchikawa S; Fujino H; Ono A; Murakami E; Okamoto W; Yamauchi M; Kawaoka T; Hayes CN; Tsuge M; Imamura M; Aikata H; Oka S
BMC Gastroenterol; 2023 Jun; 23(1):222. PubMed ID: 37380950
[TBL] [Abstract] [Full Text] [Related]
5. Time to surgery is not an oncological risk factor in HCC patients undergoing liver resection.
Otto CC; Wang G; Mantas A; Heise D; Bruners P; Lang SA; Ulmer TF; Neumann UP; Heij LR; Bednarsch J
Langenbecks Arch Surg; 2023 May; 408(1):187. PubMed ID: 37160788
[TBL] [Abstract] [Full Text] [Related]
6. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis.
Huang Z; Zhou P; Li S; Li K
Eur Radiol; 2022 Oct; 32(10):7146-7154. PubMed ID: 35639147
[TBL] [Abstract] [Full Text] [Related]
8. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma in Senegal: epidemiological, clinical and etiological aspects about 229 cases at
Diallo I; Ndiaye B; Touré M; Sow A; Mbengue A; Diawara PS; Gning SB; Mbaye PS; Fall F; Mbengue M
Pan Afr Med J; 2021; 38():99. PubMed ID: 33889265
[TBL] [Abstract] [Full Text] [Related]
10. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
[TBL] [Abstract] [Full Text] [Related]
11. SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic cancer Metabolism Biomarker of Hepatocellular Carcinoma.
Ong JR; Bamodu OA; Khang NV; Lin YK; Yeh CT; Lee WH; Cherng YG
Cells; 2021 Jan; 10(1):. PubMed ID: 33477333
[TBL] [Abstract] [Full Text] [Related]
12. Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control Studies.
Yuan JM; Wang Y; Wang R; Luu HN; Adams-Haduch J; Koh WP; Gao YT; Behari J; Lotze MT
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):388-395. PubMed ID: 33203693
[TBL] [Abstract] [Full Text] [Related]
13. Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib.
Reis D; Moura M; Freitas LC; Carvalhana S; Nogueira PJ; Gaio R; Marinho RT; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e114-e120. PubMed ID: 33177383
[TBL] [Abstract] [Full Text] [Related]
14. Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.
Yilmaz O; Daly A; Pinto A; Ashmore C; Evans S; Gupte G; Santra S; Preece MA; Mckiernan P; Kitchen S; Ayhan NY; MacDonald A
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325917
[TBL] [Abstract] [Full Text] [Related]
15. Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial.
Qin S; Ren Z; Meng Z; Chen Z; Chai X; Xiong J; Bai Y; Yang L; Zhu H; Fang W; Lin X; Chen X; Li E; Wang L; Chen C; Zou J
Lancet Oncol; 2020 Apr; 21(4):571-580. PubMed ID: 32112738
[TBL] [Abstract] [Full Text] [Related]
16. [Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
Han BL; Wang YM; Xue YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):65-70. PubMed ID: 31958933
[No Abstract] [Full Text] [Related]
17. May Neutrophil Gelatinase-Associated Lipocalin (NGAL) Level Predict Mortality in Patients with Hepatocellular Carcinoma (HCC)?
Dertli R; Biyik M; Yolacan R; Karakarcayildiz A; Keskin M; Kayar Y; Asil M
J Gastrointest Cancer; 2020 Sep; 51(3):932-938. PubMed ID: 31729643
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
[TBL] [Abstract] [Full Text] [Related]
19. Adrenal Metastasis of Hepatocellular Carcinoma in Patients following liver Resection or liver Transplantation: Experience from a Tertiary Referral Center.
Teegen EM; Mogl MT; Pratschke J; Rayes N
Int J Surg Oncol; 2018; 2018():4195076. PubMed ID: 30151282
[TBL] [Abstract] [Full Text] [Related]
20. Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study.
Kaplan DE; Mehta R; D'Addeo K; Valderrama A; Taddei TH;
Medicine (Baltimore); 2018 Jan; 97(4):e9757. PubMed ID: 29369224
[TBL] [Abstract] [Full Text] [Related]
[Next]
